SEC Form 4 · accession 0001209191-15-077475
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin L Mensink
Officer — VICE PRESIDENT, MARKETING
Period of report
Oct 29, 2015
Accepted (ET)
Oct 30, 2015 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 29, 2015 | M | 16,100 | $1.24 | A | 16,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.24 | Oct 29, 2015 | M | 16,100 | D | — | Apr 8, 2023 | Common Stock | 16,100 | 71,400 | D |
Explanation of responses
- F1The option vests as to twenty-five percent (25%) of the shares underlying the option on April 8, 2014, the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments on each monthly anniversary of the grant date thereafter, subject to continued employment or service with the Issuer through each applicable vesting date.